Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: Alexza Pharmaceuticals Inc.
CIK: 1344413
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2011-08-08
Last Filing Date: 2016-05-13
SEC Filings
Start End Frame Filed ACCN Value View
2013-01-01 2013-03-31 CY2012Q1 2013-05-14 0001193125-13-219598 $ 15,773,000 View
2011-01-01 2011-06-30 CY2011Q2I 2011-08-08 0000950123-11-074410 $ 11,852,000 View
2011-01-01 2011-09-30 CY2011Q3I 2011-11-07 0001193125-11-299809 $ -910,000 View
2012-01-01 2012-03-31 CY2012Q1I 2012-05-10 0001193125-12-225637 $ 8,833,000 View
2003-01-01 2003-12-31 CY2003 2012-03-12 0001193125-12-109810 $ 1,000 View
2011-04-01 2012-06-30 CY2012Q2I 2012-08-08 0001193125-12-344097 $ 921,000 View
2012-01-01 2012-09-30 CY2012Q3I 2012-11-06 0001193125-12-454548 $ 921,000 View
2012-01-01 2012-12-31 CY2010 2013-03-26 0001193125-13-126906 $ 12,472,000 View
2013-04-01 2013-06-30 CY2012Q2 2013-08-14 0001193125-13-333543 $ 16,375,000 View
2013-07-01 2013-09-30 CY2012Q3 2013-11-06 0001193125-13-430116 $ 17,238,000 View
2014-01-01 2014-03-31 CY2013Q1 2014-05-05 0001193125-14-182496 $ 17,282,000 View
2014-04-01 2014-06-30 CY2013Q2 2014-08-07 0001193125-14-300729 $ 17,331,000 View
2014-07-01 2014-09-30 CY2013Q3 2014-11-05 0001193125-14-398545 $ 17,371,000 View
2015-01-01 2015-03-31 CY2014Q1 2015-05-11 0001193125-15-180138 $ 19,750,000 View
2015-04-01 2015-06-30 CY2015Q2 2015-08-06 0001193125-15-281111 $ 19,775,000 View
2015-07-01 2015-09-30 CY2015Q3 2015-11-05 0001193125-15-368383 $ 19,778,000 View
2016-01-01 2016-03-31 CY2016Q1 2016-05-13 0001564590-16-019359 $ 20,807,000 View
2013-01-01 2013-12-31 CY2011 2014-03-25 0001193125-14-114451 $ 0 View
2014-01-01 2014-12-31 CY2012 2015-03-13 0001193125-15-091455 $ 0 View
2015-01-01 2015-12-31 CY2015 2016-03-28 0001564590-16-015401 $ 0 View
SEC Facts By Type
Type Name Description View
us-gaap Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest. View
us-gaap Notes Issued The fair value of notes issued in noncash investing and financing activities. View
us-gaap Notes Payable, Current Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. View
us-gaap Notes Reduction The value of notes retired (or transferred to another entity) in noncash investing or financing transactions. View
us-gaap Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other. View
us-gaap Increase (Decrease) in Other Noncurrent Assets Amount of increase (decrease) in noncurrent assets classified as other. View
us-gaap Increase (Decrease) in Other Operating Assets Amount of increase (decrease) in operating assets classified as other. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accrued Professional Fees, Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. View
us-gaap Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. View
us-gaap Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. View
us-gaap APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. View
us-gaap APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. View
us-gaap Adjustments to Additional Paid in Capital, Stock Split Amount of decrease in additional paid in capital (APIC) resulting from a stock split in which per-share par value or stated value is not changed proportionately. View
us-gaap Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. View
us-gaap Advances on Inventory Purchases Carrying value of capitalized payments made in advance for inventory that is expected to be received within one year or the normal operating cycle, if longer. View
us-gaap Amortization of Debt Discount (Premium) Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. View
us-gaap Amortization of Debt Issuance Costs and Discounts Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. View
us-gaap Area of Real Estate Property Area of a real estate property. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) This element represents the aggregate of the assets reported on the balance sheet at period end measured at fair value on a recurring basis by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. View
us-gaap Available-for-sale Securities Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading. View
us-gaap Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax Amount before tax of unrealized gain (loss) in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale. View
us-gaap Available-for-sale Securities, Amortized Cost Basis This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. View
us-gaap Available-for-sale Securities, Current Amount of investment in debt and equity securities categorized neither as trading securities nor held-to-maturity securities and intended be sold or mature one year or operating cycle, if longer. View
us-gaap Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) The net amount of gross unrealized gains (losses) for securities, at a point in time, which are categorized neither as held-to-maturity nor trading securities. View
us-gaap Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) Amount of unrealized gain (loss) on investments in debt and equity securities classified as available-for-sale securities. View
us-gaap Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) Noncurrent portion of the fair value as of the acquisition date of potential payments under the contingent consideration arrangement, including cash and shares as applicable. View
us-gaap Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. View
us-gaap Business Combination, Contingent Consideration, Liability, Current Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer. View
us-gaap Business Combination, Contingent Consideration, Liability, Noncurrent Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer. View
us-gaap Capital Lease Obligations, Current Amount of capital lease obligation due within one year or the normal operating cycle, if longer. View
us-gaap Capital Lease Obligations, Noncurrent Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Fair Value Disclosure Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes effect from exchange rate changes. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. View
us-gaap Conversion of Stock, Amount Converted "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Cost of Goods Sold (Deprecated 2018-01-31) Total costs related to goods produced and sold during the reporting period. View
us-gaap Costs and Expenses Total costs of sales and operating expenses for the period. View
us-gaap Debt Conversion, Converted Instrument, Warrants or Options Issued "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt, Current Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer. View
us-gaap Debt Instrument, Debt Default, Amount Amount of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured. View
us-gaap Debt Instrument, Convertible, Beneficial Conversion Feature Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date. View
us-gaap Debt Instrument, Interest Rate, Effective Percentage Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. View
us-gaap Debt Instrument, Periodic Payment Amount of the required periodic payments including both interest and principal payments. View
us-gaap Debt Instrument, Periodic Payment, Interest Amount of the required periodic payments applied to interest. View
us-gaap Debt Instrument, Unamortized Discount Amount, after accumulated amortization, of debt discount. View
us-gaap Debt Issuance Cost (Deprecated 2016-01-31) Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees). View
us-gaap Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction. View
us-gaap Deferred Rent Credit, Noncurrent For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date. View
us-gaap Deferred Revenue Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. View
us-gaap Deferred Revenue, Current Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. View
us-gaap Deferred Revenue, Noncurrent Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Increase (Decrease) in Other Operating Liabilities Amount of increase (decrease) in operating liabilities classified as other. View
us-gaap Deferred Tax Assets, Net Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. View
us-gaap Deferred Tax Assets, Net of Valuation Allowance Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Deferred Tax Assets, Property, Plant and Equipment Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment. View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards, Research Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Other Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs Amount of deferred tax liability attributable to taxable temporary differences from research and development costs. View
us-gaap Defined Contribution Plan, Cost Amount of cost for defined contribution plan. View
us-gaap Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. View
us-gaap Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. View
us-gaap Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) Cumulative net losses reported during the development stage. View
us-gaap Effective Income Tax Rate Reconciliation, Percent Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Employee-related Liabilities, Current Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Share-based Payment Arrangement, Amount Capitalized Amount of cost capitalized for award under share-based payment arrangement. View
us-gaap Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Amount of cost to be recognized for option under share-based payment arrangement. View
us-gaap Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt. View
us-gaap Obligations, Fair Value Disclosure Fair value of obligations measured on a recurring basis. View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property. View
us-gaap Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) The gains (losses) included in results of operations resulting from the sale or disposal of property, plant and equipment, which do not qualify for treatment as discontinued operations. This item does not include any gain (loss) recognized on the sale of oil and gas property or timber property. View
us-gaap Gain (Loss) on Disposition of Other Assets Amount of gain (loss) on sale or disposal of other assets. View
us-gaap Gains (Losses) on Restructuring of Debt For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Impairment of Long-Lived Assets Held-for-use The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). View
us-gaap Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. View
us-gaap Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). View
us-gaap Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. View
us-gaap Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. View
us-gaap Increase (Decrease) in Deferred Revenue Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. View
us-gaap Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. View
us-gaap Interest Paid, Including Capitalized Interest, Operating and Investing Activities Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. View
us-gaap Interest Payable, Current Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Inventory, Finished Goods, Gross Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer. View
us-gaap Inventory, Finished Goods, Net of Reserves Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale. View
us-gaap Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. View
us-gaap Inventory, Noncurrent, Fair Value Disclosure Fair value portion of inventory expected to be realized or consumed after one year or normal operating cycle, if longer. View
us-gaap Inventory, Raw Materials, Gross Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer. View
us-gaap Inventory, Raw Materials, Net of Reserves Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process. View
us-gaap Inventory Valuation Reserves Amount of valuation reserve for inventory. View
us-gaap Inventory, Work in Process, Gross Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer. View
us-gaap Inventory, Work in Process, Net of Reserves Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing. View
us-gaap Inventory Write-down Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. View
us-gaap Investment Income, Net, Amortization of Discount and Premium Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) Aggregation of the liabilities reported on the balance sheet measured at fair value on a recurring basis by the entity. View
us-gaap Licenses Revenue (Deprecated 2018-01-31) Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. View
us-gaap Long-term Debt Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. View
us-gaap Long-term Debt and Lease Obligation Amount of long-term debt and lease obligation, classified as noncurrent. View
us-gaap Long-term Debt and Lease Obligation, Current Amount of long-term debt and lease obligation, classified as current. View
us-gaap Long-Term Debt, Maturity, after Year Five Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Long-Term Debt, Maturity, Year One Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Long-Term Debt, Maturity, Year Five Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Long-Term Debt, Maturity, Year Four Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Long-Term Debt, Maturity, Year Three Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Long-Term Debt, Maturity, Year Two Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Long-Term Debt, Maturity, Remainder of Fiscal Year Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year. View
us-gaap Long-term Debt, Excluding Current Maturities Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. View
us-gaap Notes Payable, Noncurrent Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. View
us-gaap Loss Contingency Accrual, Provision Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges. View
us-gaap Manufacturing Costs The aggregate costs incurred in the production of goods for sale. View
us-gaap Marketable Securities, Current Amount of investment in marketable security, classified as current. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Investing Activities, Continuing Operations Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Cash Provided by (Used in) Operating Activities, Continuing Operations Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Number of Reportable Segments Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Operating Leases, Future Minimum Payments Due Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year. View
us-gaap Operating Leases, Future Minimum Payments Due, Next Twelve Months Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Due in Five Years Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Due in Four Years Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Due in Three Years Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Due in Two Years Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Due Thereafter Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Income Statement, Lease Revenue The total amount of revenue recognized for the period from operating leases, including minimum lease revenue, contingent revenue, percentage revenue and sublease revenue. View
us-gaap Operating Leases, Rent Expense, Net Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income. View
us-gaap Other Accrued Liabilities, Current Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. View
us-gaap Other Assets, Noncurrent Amount of noncurrent assets classified as other. View
us-gaap Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss). View
us-gaap Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) This element represents Other Comprehensive Income or Loss, Net of Tax, for the period. Includes deferred gains or losses on qualifying hedges, unrealized holding gains or losses on available-for-sale securities, minimum pension liability, and cumulative translation adjustment. While for technical reasons this element has no balance attribute, the default assumption is a credit balance consistent with its label. View
us-gaap OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. View
us-gaap Other Liabilities Amount of liabilities classified as other. View
us-gaap Other Liabilities, Fair Value Disclosure Fair value portion of other liabilities. View
us-gaap Other Liabilities, Noncurrent Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. View
us-gaap Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period. View
us-gaap Payments to Acquire Additional Interest in Subsidiaries The cash outflow associated with the purchase of noncontrolling interest during the period. View
us-gaap Payments to Acquire Businesses, Gross The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. View
us-gaap Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Proceeds from Issuance of Convertible Preferred Stock The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. View
us-gaap Proceeds from Issuance of Long-term Debt The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer. View
us-gaap Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). View
us-gaap Proceeds from Noncontrolling Interests Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership. View
us-gaap Proceeds from (Repayments of) Restricted Cash, Financing Activities The net cash inflow or outflow from cash and cash items that are not available for withdrawal or usage. View
us-gaap Proceeds from Sale and Maturity of Marketable Securities The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. View
us-gaap Proceeds from Sale of Available-for-sale Securities The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities. View
us-gaap Proceeds from Sale of Property, Plant, and Equipment The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. View
us-gaap Production Related Impairments or Charges Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Property, Plant and Equipment, Gross Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Receivables, Net, Current The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value. View
us-gaap Repayments of Long-term Debt The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer. View
us-gaap Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation. View
us-gaap Research and Development Expense (Excluding Acquired in Process Cost) The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. View
us-gaap Research and Development in Process The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. View
us-gaap Restricted Cash and Cash Equivalents Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Restricted Cash and Cash Equivalents, Current Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Restricted Cash and Cash Equivalents, Noncurrent Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Restricted Cash and Investments, Current The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal. View
us-gaap Restructuring Charges Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenue from Grants (Deprecated 2018-01-31) Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements. View
us-gaap Revenue Recognition, Milestone Method, Revenue Recognized The amount of consideration recognized during the period for the milestone or milestones. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Sale of Stock, Price Per Share Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. View
us-gaap Sales Revenue, Goods, Net (Deprecated 2018-01-31) Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Number of additional shares authorized for issuance under share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted average price of options that were either forfeited or expired. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. View
us-gaap Share Price Price of a single share of a number of saleable stocks of a company. View
us-gaap Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stock Issued During Period, Shares, Employee Stock Purchase Plans Number of shares issued during the period as a result of an employee stock purchase plan. View
us-gaap Stock Issued During Period, Shares, New Issues Number of new stock issued during the period. View
us-gaap Stock Issued During Period, Shares, Reverse Stock Splits Reduction in the number of shares during the period as a result of a reverse stock split. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Issued During Period, Value, Acquisitions Value of stock issued pursuant to acquisitions during the period. View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Stock Issued During Period, Value, Employee Stock Purchase Plan Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Restricted Stock Award, Gross Aggregate value of stock related to Restricted Stock Awards issued during the period. View
us-gaap Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options. View
us-gaap Stock Repurchased During Period, Value Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. View
us-gaap Tangible Asset Impairment Charges The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value. View
us-gaap Unrealized Loss on Securities The increase (decrease), resulting in a loss, in the difference between the fair value and the carrying value, or in the comparative fair values, of securities held at each balance sheet date, that was included in earnings for the period. View
us-gaap Unrecognized Tax Benefits Amount of unrecognized tax benefits. View
us-gaap Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return. View
us-gaap Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns. View
us-gaap Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities. View
us-gaap Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return. View
us-gaap Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns. View
us-gaap Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations. View
us-gaap Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. View
us-gaap Warrants and Rights Outstanding Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. View
us-gaap Warrants Not Settleable in Cash, Fair Value Disclosure Fair value portion of warrants not settleable in cash classified as equity. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
invest Investment Warrants, Exercise Price Exercise price of the warrants. View
us-gaap Accelerated Share Repurchases, Final Price Paid Per Share Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. View
us-gaap Accretion (Amortization) of Discounts and Premiums, Investments The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. View
us-gaap APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement. View
us-gaap Amortization of Intangible Assets The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. View
us-gaap Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale. View
us-gaap Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) Current portion of the fair value as of the acquisition date of potential payments under the contingent consideration arrangement, including cash and shares as applicable. View
us-gaap Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (Deprecated 2013-01-31) This element represents the amount of any change, including any differences arising upon settlement, recognized during the reporting period in the value of a liability, arising from an item of contingent consideration, assumed in a business combination. View
us-gaap Cash, Cash Equivalents, and Short-term Investments Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable. View
us-gaap Cash Equivalents, at Carrying Value Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Deferred Tax Assets, in Process Research and Development Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price). View
us-gaap Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price. View
us-gaap Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) Risk-free interest rate assumption used in valuing an instrument. View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3). View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Increase (Decrease) in Receivables The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities. View
us-gaap Increase (Decrease) in Restricted Cash The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Net Cash Provided by (Used in) Financing Activities, Continuing Operations Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Number of Operating Segments Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average price at which option holders acquired shares when converting their stock options into shares. View
us-gaap Payments to Acquire Available-for-sale Securities The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Issuance Initial Public Offering The cash inflow associated with the amount received from entity's first offering of stock to the public. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Repayment of Notes Receivable from Related Parties The cash inflow from a loan, supported by a promissory note, granted to related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Revenue, Net (Deprecated 2018-01-31) Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. View
us-gaap Secured Debt Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. View
us-gaap Unrealized Gain on Securities The increase (decrease), resulting in a gain, in the difference between the fair value and the carrying value, or in the comparative fair values, of securities held at each balance sheet date, that was included in earnings for the period. View
us-gaap Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall). View
Chart of Accounts => Accounts
Name View
Accelerated Share Repurchases, Final Price Paid Per Share View
Accounts Payable, Current View
Accrued Professional Fees, Current View
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment View
Accumulated Other Comprehensive Income (Loss), Net of Tax View
Additional Paid in Capital, Common Stock View
APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition View
APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition View
APIC, Share-based Payment Arrangement, Increase for Cost Recognition View
Adjustments to Additional Paid in Capital, Stock Split View
Adjustments to Additional Paid in Capital, Warrant Issued View
Advances on Inventory Purchases View
Amortization of Debt Discount (Premium) View
Amortization of Debt Issuance Costs and Discounts View
Amortization of Intangible Assets View
Area of Real Estate Property View
Assets View
Assets, Current View
Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) View
Available-for-sale Securities View
Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax View
Available-for-sale Securities, Amortized Cost Basis View
Available-for-sale Securities, Current View
Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) View
Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) View
Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) View
Business Acquisition, Contingent Consideration, at Fair Value, Current (Deprecated 2013-01-31) View
Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) View
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (Deprecated 2013-01-31) View
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability View
Business Combination, Contingent Consideration, Liability, Noncurrent View
Capital Lease Obligations, Current View
Capital Lease Obligations, Noncurrent View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Fair Value Disclosure View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Comprehensive Income (Loss), Net of Tax, Attributable to Parent View
Conversion of Stock, Amount Converted View
Cost of Goods Sold (Deprecated 2018-01-31) View
Costs and Expenses View
Debt Conversion, Converted Instrument, Warrants or Options Issued View
Debt, Current View
Debt Instrument, Debt Default, Amount View
Debt Instrument, Convertible, Beneficial Conversion Feature View
Debt Instrument, Interest Rate, Effective Percentage View
Debt Instrument, Periodic Payment View
Debt Instrument, Periodic Payment, Interest View
Debt Instrument, Unamortized Discount View
Debt Issuance Cost (Deprecated 2016-01-31) View
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction View
Deferred Rent Credit, Noncurrent View
Deferred Revenue View
Deferred Revenue, Current View
Deferred Revenue, Noncurrent View
Deferred Tax Assets, Gross View
Deferred Tax Assets, in Process Research and Development View
Deferred Tax Assets, Net View
Deferred Tax Assets, Net of Valuation Allowance View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Property, Plant and Equipment View
Deferred Tax Assets, Tax Credit Carryforwards, Research View
Deferred Tax Assets, Tax Deferred Expense, Other View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities View
Deferred Tax Assets, Valuation Allowance View
Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs View
Defined Contribution Plan, Cost View
Depreciation View
Depreciation, Depletion and Amortization View
Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) View
Earnings Per Share, Basic and Diluted View
Effective Income Tax Rate Reconciliation, Percent View
Employee-related Liabilities, Current View
Share-based Payment Arrangement, Amount Capitalized View
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount View
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount View
Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) View
Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) View
Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) View
Obligations, Fair Value Disclosure View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings View
Revenue from Grants (Deprecated 2018-01-31) View
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property View
Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) View
Gain (Loss) on Disposition of Other Assets View
Gains (Losses) on Restructuring of Debt View
General and Administrative Expense View
Impairment of Long-Lived Assets Held-for-use View
Income Tax Expense (Benefit) View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount View
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount View
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount View
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount View
Increase (Decrease) in Accounts Payable View
Increase (Decrease) in Accrued Liabilities View
Increase (Decrease) in Deferred Revenue View
Increase (Decrease) in Inventories View
Increase (Decrease) in Other Noncurrent Assets View
Increase (Decrease) in Other Operating Assets View
Increase (Decrease) in Other Operating Liabilities View
Increase (Decrease) in Prepaid Expense and Other Assets View
Increase (Decrease) in Receivables View
Increase (Decrease) in Restricted Cash View
Interest Expense View
Interest Paid, Including Capitalized Interest, Operating and Investing Activities View
Interest Payable, Current View
Inventory, Finished Goods, Gross View
Inventory, Finished Goods, Net of Reserves View
Inventory, Net View
Inventory, Noncurrent, Fair Value Disclosure View
Inventory, Raw Materials, Gross View
Inventory, Raw Materials, Net of Reserves View
Inventory Valuation Reserves View
Inventory, Work in Process, Gross View
Inventory, Work in Process, Net of Reserves View
Inventory Write-down View
Investment Income, Net, Amortization of Discount and Premium View
Liabilities and Equity View
Liabilities, Current View
Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) View
Licenses Revenue (Deprecated 2018-01-31) View
Long-term Debt View
Long-term Debt and Lease Obligation View
Long-term Debt and Lease Obligation, Current View
Long-Term Debt, Maturity, after Year Five View
Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months View
Long-Term Debt, Maturity, Year One View
Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two View
Long-Term Debt, Maturity, Year Five View
Long-Term Debt, Maturity, Year Four View
Long-Term Debt, Maturity, Year Three View
Long-Term Debt, Maturity, Year Two View
Long-Term Debt, Maturity, Remainder of Fiscal Year View
Long-term Debt, Excluding Current Maturities View
Notes Payable, Noncurrent View
Loss Contingency Accrual, Provision View
Manufacturing Costs View
Marketable Securities, Current View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Financing Activities, Continuing Operations View
Net Cash Provided by (Used in) Investing Activities View
Net Cash Provided by (Used in) Operating Activities View
Net Cash Provided by (Used in) Operating Activities, Continuing Operations View
Net Income (Loss) Attributable to Parent View
Net Income (Loss) Attributable to Noncontrolling Interest View
Notes Issued View
Notes Payable, Current View
Notes Reduction View
Number of Operating Segments View
Number of Reportable Segments View
Operating Income (Loss) View
Operating Leases, Future Minimum Payments Due View
Operating Leases, Future Minimum Payments, Due in Five Years View
Operating Leases, Future Minimum Payments, Due in Four Years View
Operating Leases, Future Minimum Payments, Due in Three Years View
Operating Leases, Future Minimum Payments, Due in Two Years View
Operating Leases, Future Minimum Payments, Due Thereafter View
Operating Leases, Income Statement, Lease Revenue View
Operating Leases, Rent Expense, Net View
Other Accrued Liabilities, Current View
Other Assets, Noncurrent View
Other Comprehensive Income (Loss), Net of Tax View
Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) View
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax View
Other Liabilities View
Other Liabilities, Fair Value Disclosure View
Other Liabilities, Noncurrent View
Payments for Repurchase of Common Stock View
Payments to Acquire Additional Interest in Subsidiaries View
Payments to Acquire Available-for-sale Securities View
Payments to Acquire Businesses, Gross View
Payments to Acquire Property, Plant, and Equipment View
Preferred Stock, Par or Stated Value Per Share View
Preferred Stock, Shares Authorized View
Proceeds from Issuance of Convertible Preferred Stock View
Proceeds from Issuance of Long-term Debt View
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale View
Proceeds from Noncontrolling Interests View
Proceeds from (Repayments of) Restricted Cash, Financing Activities View
Proceeds from Sale and Maturity of Marketable Securities View
Proceeds from Sale of Available-for-sale Securities View
Proceeds from Sale of Property, Plant, and Equipment View
Production Related Impairments or Charges View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Property, Plant and Equipment, Gross View
Property, Plant and Equipment, Net View
Receivables, Net, Current View
Repayment of Notes Receivable from Related Parties View
Repayments of Long-term Debt View
Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security View
Research and Development Expense View
Research and Development Expense (Excluding Acquired in Process Cost) View
Research and Development in Process View
Restricted Cash and Cash Equivalents View
Restricted Cash and Cash Equivalents, Current View
Restricted Cash and Cash Equivalents, Noncurrent View
Restricted Cash and Investments, Current View
Restructuring Charges View
Retained Earnings (Accumulated Deficit) View
Revenues View
Sale of Stock, Price Per Share View
Sales Revenue, Goods, Net (Deprecated 2018-01-31) View
Revenue, Net (Deprecated 2018-01-31) View
Secured Debt View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value View
Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price View
Share Price View
Shares, Outstanding View
Stockholders' Equity Attributable to Parent View
Stock Issued During Period, Shares, Employee Stock Purchase Plans View
Stock Issued During Period, Shares, New Issues View
Stock Issued During Period, Shares, Reverse Stock Splits View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, Acquisitions View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Stock Issued During Period, Value, Employee Stock Purchase Plan View
Stock Issued During Period, Value, Restricted Stock Award, Gross View
Stock Issued During Period, Value, Stock Options Exercised View
Stock Repurchased During Period, Value View
Tangible Asset Impairment Charges View
Unrealized Gain on Securities View
Unrealized Loss on Securities View
Unrecognized Tax Benefits View
Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions View
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions View
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities View
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions View
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions View
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount View
Warrants and Rights Outstanding View
Warrants Not Settleable in Cash, Fair Value Disclosure View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation View
Accounts Receivable, after Allowance for Credit Loss, Current View
Accretion (Amortization) of Discounts and Premiums, Investments View
Business Combination, Contingent Consideration, Liability, Current View
Cash, Cash Equivalents, and Short-term Investments View
Cash Equivalents, at Carrying Value View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Class of Warrant or Right, Number of Securities Called by Warrants or Rights View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value View
Net Cash Provided by (Used in) Investing Activities, Continuing Operations View
Operating Leases, Future Minimum Payments Due, Next Twelve Months View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Preferred Stock, Value, Issued View
Prepaid Expense and Other Assets, Current View
Proceeds from Issuance Initial Public Offering View
Proceeds from Issuance of Common Stock View
Revenue Recognition, Milestone Method, Revenue Recognized View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price View
Stock Issued During Period, Value, New Issues View
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations View